Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Thang N Tran"'
Publikováno v:
International Journal of Climate Change Strategies and Management, Vol 13, Iss 4/5, Pp 492-510 (2021)
Purpose – This paper aims to examine adaptive livelihood strategies used by small-scale fishing households in the two coastal communities in Central Vietnam under the context of climate change-related stressors. Design/methodology/approach – Fiel
Externí odkaz:
https://doaj.org/article/0ce76178981d42ec87e4df5e8677d109
Autor:
Alyssa Halper, Mary C. Hooke, Maria Teresa Gonzalez-Bolanos, Nancy Vanderburg, Thang N. Tran, Jane Torkelson, Kyriakie Sarafoglou
Publikováno v:
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-7 (2017)
Abstract Background Children with congenital adrenal hyperplasia (CAH) require life-long glucocorticoid replacement and have daily intermittent hyper/hypocortisolemia and hyperandrogenemia. Health-related quality of life (HRQL) is important for under
Externí odkaz:
https://doaj.org/article/51fb71ad48f9449eb3fadd5268edeef1
Publikováno v:
International Journal of Climate Change Strategies and Management. 13:492-510
Purpose This paper aims to examine adaptive livelihood strategies used by small-scale fishing households in the two coastal communities in Central Vietnam under the context of climate change-related stressors. Design/methodology/approach Field data w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a34fdf8169734d7302d9eace38cfccdc
https://doi.org/10.1108/ijccsm-04-2020-0034
https://doi.org/10.1108/ijccsm-04-2020-0034
Autor:
Brian A. Willis, Mariam A. Ahmed, Thang N. Tran, Richard C. Brundage, Maria Teresa Gonzalez-Bolanos, Kyriakie Sarafoglou, Mahmoud Al-Kofahi, Mutaz M. Jaber, Cheryl L. Zimmerman
Publikováno v:
British journal of clinical pharmacology. 87(3)
Aims The aim of this study was to characterize the pharmacokinetic/pharmacodynamic relationships of cortisol and the adrenal biomarkers 17-hydroxyprogesterone and androstenedione in children with congenital adrenal hyperplasia (CAH). Methods A nonlin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2334e88337b1406fe256c3c4e080f4b4
https://pubmed.ncbi.nlm.nih.gov/32652643
https://pubmed.ncbi.nlm.nih.gov/32652643
Autor:
Jane L. Torkelson, Alyssa Halper, Mary C. Hooke, Thang N. Tran, Nancy Vanderburg, Maria Teresa Gonzalez-Bolanos, Kyriakie Sarafoglou
Publikováno v:
Health and Quality of Life Outcomes, Vol 15, Iss 1, Pp 1-7 (2017)
Health and Quality of Life Outcomes
Health and Quality of Life Outcomes
Background Children with congenital adrenal hyperplasia (CAH) require life-long glucocorticoid replacement and have daily intermittent hyper/hypocortisolemia and hyperandrogenemia. Health-related quality of life (HRQL) is important for understanding
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5685f9c9ade4617d1d75752f5256321f
http://link.springer.com/article/10.1186/s12955-017-0769-7
http://link.springer.com/article/10.1186/s12955-017-0769-7
Autor:
Po Yee Yip, Maija R.J. Kohonen-Corish, Nick Pavlakis, Wendy A Cooper, Adrian V. Lee, Bing Yu, Sandra A O'Toole, Lisa G. Horvath, Stephen Clarke, Matthew Links, Bob T. Li, Thang N Tran, Anthony J. Gill, Trina Lum, Christina I. Selinger
Publikováno v:
Histopathology. 70:402-411
Aims To assess the prevalence of ROS1 rearrangements in a retrospective and prospective diagnostic Australian cohort and evaluate the effectiveness of immunohistochemical screening. Methods and results A retrospective cohort of 278 early stage lung a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41183c915438d9b95408413ade48af6e
https://doi.org/10.1111/his.13076
https://doi.org/10.1111/his.13076
Autor:
Thang N Tran, Glen Reid, Nico van Zandwijk, Michael P. Vallely, Stephen Clarke, T. Korse, Nick Pavlakis, Michaela B. Kirschner, Mark P. Molloy, Sjaak Burgers, Daan van den Broek, J. James B. Edelman, Brian C. McCaughan, Wendy A Cooper, Casey M. Wright, Steven Kao
Publikováno v:
British Journal of Cancer
Background: We aimed to identify prognostic blood biomarkers using proteomics-based approaches in malignant pleural mesothelioma (MPM). Methods: Plasma samples from 12 MPM patients were used for exploratory mass spectrometry and ELISA analyses. The s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99af5c5def362c5bbaa930074ab9b304
http://europepmc.org/articles/PMC4782201
http://europepmc.org/articles/PMC4782201
Autor:
Steven Kao, Jennifer H. Yearley, Thang N Tran, Michael Boyer, Po Yee Yip, Wendy A Cooper, Maija R.J. Kohonen-Corish, Sandra A O'Toole, Ricardo E. Vilain, Richard A. Scolyer, Lisa G. Horvath, Christina I. Selinger, Jason Madore, Bing Yu, Brian C. McCaughan
Publikováno v:
Lung Cancer. 89:181-188
Immune checkpoint blockade using inhibitors of programmed death-1 have shown promise in early phase clinical trials in NSCLC and programmed death-ligand 1 (PD-L1) tumoral expression could potentially be a useful predictive marker. Data reporting the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9f4be91a6baa7e0bfedf75b0408e1f05
https://doi.org/10.1016/j.lungcan.2015.05.007
https://doi.org/10.1016/j.lungcan.2015.05.007
Autor:
Thang N. Tran, Catherine Mitchell, Cuong Duong, Nicholas J. Clemons, Kate H. Brettingham-Moore, Wayne A. Phillips
Publikováno v:
Journal of Surgical Oncology. 108:113-120
Background and Objectives The phosphatidylinositide 3-kinase (PI3K) pathway is an important signalling pathway that is frequently activated in cancer cells. This has led to the emergence of PI3K inhibitors as potential new treatment modalities for ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::46135f8ca253c184b97988f701bc3a3d
https://doi.org/10.1002/jso.23357
https://doi.org/10.1002/jso.23357
Autor:
Brian C. McCaughan, Catherine Kennedy, Wendy A Cooper, Christina I. Selinger, Maija R.J. Kohonen-Corish, Thang N Tran, Sandra A O'Toole
Publikováno v:
Clinical lung cancer. 17(1)
Introduction Mesenchymal epithelial transition factor (MET) is a promising therapeutic target in non–small-cell lung cancer (NSCLC) but there are limited data about MET alterations in treatment-naive NSCLC and whether or not these changes are consi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6570626b58794708a3e501714f3c1b07
https://pubmed.ncbi.nlm.nih.gov/26395411
https://pubmed.ncbi.nlm.nih.gov/26395411